Audio is streamed directly from the publisher (audioboom.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
The FDA is moving to streamline the approval process for generic biologic drugs. What kinds of drugs are we talking about and how much of a price reduction could we see from this major change? We asked Dr. Fred Browne of Griffin Health.
For the full FDA press release: https://www.fda.gov/news-events/press-announcements/fda-moves-accelerate-biosimilar-development-and-lower-drug-costs
Image Courtesy of Griffin Health
For the full FDA press release: https://www.fda.gov/news-events/press-announcements/fda-moves-accelerate-biosimilar-development-and-lower-drug-costs
Image Courtesy of Griffin Health